HWHG(SH:600079) Ge Long Hui A P P·2025-11-28 10:35Core Viewpoint - The company, Renfu Pharmaceutical, is establishing a new investment fund focused on the health sector, collaborating with various investment institutions to leverage their expertise and resources while ensuring stable development of its main business [1] Group 1: Investment Fund Details - Renfu Pharmaceutical, along with partners including Wuhan Ruicheng and several funds, is setting up the Wuhan Ruicheng New Drug Technology Achievement Transformation Venture Capital Fund Center (Limited Partnership) [1] - The initial capital contribution for the Ruicheng Venture Capital Fund is set at 250 million yuan, primarily targeting high-tech industries in the health sector [1] - The company will act as a limited partner, committing 75 million yuan, which represents 30% of the total initial capital contribution [1] Group 2: Ownership and Related Party Transactions - The company holds a 32.25% equity stake in Wuhan Ruicheng, which is classified as an associated party under the Shanghai Stock Exchange listing rules [1] - The joint investment constitutes a related party transaction due to the ownership structure [1]